James B. Bucher's most recent trade in Climb Bio Inc. was a trade of 95,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 31, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Climb Bio Inc | James B. Bucher | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 95,000 | 95,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc | James B. Bucher | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 95,000 | 95,000 | - | - | Stock Option (Right to Buy) |